Screening and cloning of gene encoding HBeAg interacting protein in hepatocytes

World Chinese Journal of Digestology

Volumn 11, Issue 4, 2003, Pages 422-425

  Lu, Yin Ying ^a   Wang, Lin ^a   Li, Ke ^a   Liu, Yan ^a   Cheng, Jun ^a   Zhang, Ling Xia ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A SYNTHASE 2; AMINO ACID OXIDASE; ATP SYNTHASE 6; CD81 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C8; COMPLEMENT FACTOR H; CYTOCHROME B; EPIMERASE; FERRITIN; FRUCTOSE BISPHOSPHATE ALDOLASE; HEPATITIS B(E) ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; METALLOTHIONEIN; PLASMID DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; RETINOIC ACID RECEPTOR; SYNDECAN 1; TAZAROTENE; UNCLASSIFIED DRUG;

ARTICLE; DIPLOIDY; DNA LIBRARY; DNA SEQUENCE; ESCHERICHIA COLI; EXTRACTION; LIVER CELL; MOLECULAR CLONING; PLASMID; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; SCREENING; TWO HYBRID SYSTEM; YEAST CELL;

EID: 0037391644     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v11.i4.422     Document Type: Article

References (34)

1. Zhevachevsky NG, Nomokonova NY, Beklemishev AB, Belov GF. Dynamic study of HBsAg and HBeAg in saliva samples from patients with hepatitis B infection: diagnostic and epidemiological significance. J Med Virol 2000;61:433-438
2. Milich DR. Do T cells "see" the hepatitis B core and e antigens differently? Gastroenterology 1999;116:765-768
3. Barth H, Klein R, Berg PA, Wiedenmann B, Hopf U, Berg T. Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B. Hepatogastroenterology 2001;48:553-555
4. Merkle H, Deutschle T, Gastrock-Balitsch I, Nusser P, Knehr S, Reifenberg K. H-2(d) mice born to and reared by HBeAg- transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products. Virology 2000;273:149-159
5. Khakoo SI, Ling R, Scott I, Dodi AI, Harrison TJ, Dusheiko GM, Madrigal JA. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut 2000;47:137-143
6. Zavaglia C, Severini R, Tinelli C, Franzone JS, Airoldi A, Tempini S, Bettale G, Ideo G. A randomized, controlled study of thymosin-alphal therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci 2000;45:690-696
7. Krastev Z, Jelev D, Antonov K, Alagozian V, Kotzev I. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients-a pilot study. Hepatogastroenterology 1999;46:3184-3188
8. Papatheodoridis GV, Hadziyannis SJ. Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat 2001;8:311-321
9. Khakoo SI, Ling R, Scott I, Dodi AI, Hanison TJ, Dusheiko GM, Madrigal JA. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut 2000;47:137-143
10. Dong J, Cheng J, Wang Q, Huang FJ, Shi S, Zhang G, Hong Y, Li L, Si C. The study on heterogeneity of hepatitis B virus DNA. Zhonghua Yixue Zazhi 2002;82:81-85
11. Riedl P, Stober D, Oehninger C, Melber K, Reimann J, Schirmbeck R. Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. J Immunol 2002;168:4951-4959
12. Wang XZ, Jiang XR, Chen XC, Chen ZX, Li D, Lin JY, Tao QM. Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system. World J Gastroenterol 2002;8:95-98
13. Nagpal S, Ghosn CR, Chandraratna RA. Identification of nuclear receptor interacting proteins using yeast two-hybrid technology. Methods Mol Biol 2001;176:359-376
14. Serebriiskii IG, Toby GG, Finley RL Jr, Golemis EA. Related Articles Genomic analysis utilizing the yeast two-hybrid system. Methods Mol Biol 2001;175:415-454
15. Gietz RD, Woods RA. Screening for protein-protein interactions in the yeast two-hybrid system. Methods Mol Biol 2002;185:471-486
16. Zhen Z. Progress in proteomics. Shengwu Gongcheng Xuebao 2001; 17:491-493
17. Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, Monk P, Higginbottom A, Levy S, McKeating JA. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 1999;73:6235-6244
18. Cao Z, Bai Y, Yang X, Liu J, Li B, Li F. Study of iron metabolism abnormality in the hepatocyte damage of hepatitis B. Zhonghua Ganzangbing Zazhi 2001;9:37-39
19. Bayraktar Y, Saglam F, Temizer A, Uzunalimodlu B, van Thiel DH. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B. Hepatogastroenterology 1998;45:2322-2327
20. Huang XF, Luu-The V. Gene structure, chromosomal localization and analysis of 3-ketosteroid reductase activity of the human 3(alpha - >beta)-hydroxysteroid epimerase. Biochim Biophys Acta 2001;1520:124-130
21. Chen J, Chen M, Zhao B, Wang Y. Effects of acupuncture on the immunological functions in hepatitis B virus carriers. J Tradit Chin Med 1999;19:268-272
22. Ruiz A, Kuehn MH, Andorf JL, Stone E, Hageman GS, Bok D. Genomic organization and mutation analysis of the gene encoding lecithin retinol acyltransferase in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2001;42:31-37
23. Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, Smith P, Ke Y. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst 2002;94:482-490
24. Duvic M, Helekar B, Schulz C, Cho M, Disepio D, Hager C, DiMao D, Hazarika P, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman SM, Chandraratna RAS, Robinson NA, Deucher A, Ecker RL, Nagpal S. Expression of a retinoid-inducible tumor suppressor, tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 2000;6:3249-3259
25. Fang J, Sawa T, Akaike T, Maeda H. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide. Cancer Res 2002;62:3138-3143
26. Fujimoto Y, Kohgo Y. Alteration of genomic structure and/or expression of cancer associated genes in hepatocellular carcinoma. Rinsho Byori 1998;46:9-14
27. Fujimoto Y, Kohgo Y. Syndecan-1. Nippon Rinsho 2001;59(Suppl 6):184-188
28. Jacobs W, Bogers J, Van Marck E. Distinct B-cell populations are present in hepatic and intestinal Schistosoma mansoni granulomas. Acta Gastroenterol Belg 1999;62:178-181